The impact of serum magnesium and calcium on the risk of epilepsy: A mendelian randomization study
CNS Neuroscience & Therapeutics · 2023
DOI: 10.1111/cns.14248 ↗Kurz gefasst
Metaanalyse in der Zeitschrift CNS Neuroscience & Therapeutics, 2023. Verfasst von Xiaoming Guo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Epilepsy, Epilepsy, Generalized. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Aims
To investigate the causal role of serum magnesium and calcium in epilepsy or any of its subtypes through Mendelian randomization (MR) approach.
Methods
Single nucleotide polymorphisms (SNPs) associated with serum magnesium and calcium were used as the instrumental variables. MR analyses were performed using the summary‐level data for epilepsy extracted from International League Against Epilepsy Consortium (15,212 cases and 29,677 controls) to obtain the causal estimates. The analyses were replicated using FinnGen data (7224 epilepsy cases and 208,845 controls), and a meta‐analysis was then conducted.
Results
The result of combined analyses showed that higher serum magnesium concentrations was associated with a reduced risk of overall epilepsy (odds ratios [OR] = 0.28, 95% confidence interval [CI], 0.12–0.62, p = 0.002). In ILAE, higher serum magnesium was suggestively associated with reduced risks of focal epilepsy (OR = 0.25, 95% CI 0.10–0.62, p = 0.003). However, the results cannot be repeated in sensitivity analyses. As for serum calcium, the results did not reach statistical significance with overall epilepsy (OR = 0.60, 95% CI, 0.31–1.17, p = 0.134). However, genetically predicted serum calcium concentrations showed an inverse association with risk of generalized epilepsy (OR = 0.35, 95% CI, 0.17–0.74, p = 0.006).
Conclusion
The current MR analysis did not support a causal relationship between serum magnesium and epilepsy, but showed a causally negative association between genetically determined serum calcium and generalized epilepsy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Department of Neurosurgery, Tongde Hospital of Zhejiang Province, Hangzhou, China.
- Department of Geriatrics, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
ORCID-Profile: Yuan Hong
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Guo, X., Zhu, Y., Ying, C., Xu, K., & Hong, Y. (2023). The impact of serum magnesium and calcium on the risk of epilepsy: A mendelian randomization study. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.14248
Vancouver
Guo X, Zhu Y, Ying C, Xu K, Hong Y. The impact of serum magnesium and calcium on the risk of epilepsy: A mendelian randomization study. CNS Neuroscience & Therapeutics. 2023. doi:10.1111/cns.14248
BibTeX
@article{Guo2023,
author = {Guo, Xiaoming and Zhu, Yueli and Ying, Caidi and Xu, Ke and Hong, Yuan},
title = {The impact of serum magnesium and calcium on the risk of epilepsy: A mendelian randomization study},
journal = {CNS Neuroscience & Therapeutics},
year = {2023},
doi = {10.1111/cns.14248}
}
EUVIMED